BIOSENSE WEBSTER INC QDOT-MICRO, BI-DIRECTIONAL, D-F CURVE, C3, SPLIT HANDLE; SIMILAR DEVICE D134801, PMA # P030031/S078
|
Back to Search Results |
|
Catalog Number D139505 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Fever (1858)
|
Event Date 07/08/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
Information received indicates that the device is not available for return, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation (mre) cannot be conducted because no valid lot number was provided by the customer.Note: the provided lot number was not recognized as a valid lot number in our system, as such, the manufactured date and the expiration dates could not be obtained.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Note: the ¿suspected medical device¿ reported is not marketed in usa or approved by the fda.However, it is being reported as biosense webster considers this as a similar device to thermocool® smart touch¿ electrophysiology catheter approved under p030031/s053.Initial reporter phone: (b)(6).If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Event Description
|
It was reported that a (b)(6) year-old female underwent an atrial fibrillation (afib) ablation procedure with a qdot-micro, bi-directional, d-f curve, c3, split handle and the patient developed a fever requiring medication and prolonged hospitalization.It was reported the patient developed a fever which required antibiotic therapy and prolonged hospitalization.The adverse event was assessed as unlikely related to the study device and probably related to the procedure and not related to any other procedure.Patient¿s admission date: (b)(6) 2021 & discharge date: (b)(6) 2021.
|
|
Manufacturer Narrative
|
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).Correction: on 7-jan-2022, it was noticed that the following information was inadvertently omitted from the 3500a initial medwatch report: on 16-jul-2021 and 18-jul-2021 additional information was received indicated the principal investigator assessed this event index procedure related and moderate in severity.The event was expected/anticipated.No medication was required other than the antibiotic therapy.The patient¿s outcome was reported as recovered/resolved.
|
|
Search Alerts/Recalls
|
|
|